Eisai Co., Ltd. (TYO:4523)
4,279.00
+37.00 (0.87%)
Feb 21, 2025, 3:30 PM JST
Eisai Employees
Eisai had 11,067 employees as of March 31, 2024. The number of employees decreased by 9 or -0.08% compared to the previous year.
Employees
11,067
Change (1Y)
-9
Growth (1Y)
-0.08%
Revenue / Employee
71.53M JPY
Profits / Employee
5.31M JPY
Market Cap
1,206.20B
Employees Chart
Employees History
Related Stocks
Company Name | Employees |
---|---|
Chugai Pharmaceutical | 7,604 |
Takeda Pharmaceutical Company | 49,281 |
Daiichi Sankyo Company | 18,726 |
HOYA Corporation | 35,702 |
Otsuka Holdings | 34,388 |
Astellas Pharma | 14,754 |
Olympus | 28,838 |
Shionogi & | 4,959 |
Eisai News
- 12 days ago - Q3 2025 Eisai Co Ltd Earnings Presentation Transcript - GuruFocus
- 14 days ago - Eisai projects 42.5B yen global revenue for LEQEMBI in FY2024 amid pathway expansion - Seeking Alpha
- 14 days ago - Eisai Co., Ltd. (ESALF) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 15 days ago - Eisai GAAP EPS of ¥160.14, revenue of ¥601.16B; reaffirms FY outlook - Seeking Alpha
- 22 days ago - Europe to review safety data for Eisai-Biogen Alzheimer's drug - Reuters
- 26 days ago - FDA approves IV maintenance dosing of Leqembi® (lecanemab-irmb) for the treatment of early Alzheimer's Disease in the US - Benzinga
- 26 days ago - US FDA OKs monthly maintenance dosing for Eisai/Biogen's Alzheimer's drug - Reuters
- 26 days ago - FDA Approves LEQEMBI® (lecanemab-irmb) IV Maintenance Dosing for the Treatment of Early Alzheimer's Disease - PRNewsWire